Abstract:
A diesel fuel composition containing metallic additives that are stabilized against phase separation. The diesel fuel contains a colloidally dispersed or solubilized metal catalyst compound, which can be used for diesel particulate trap regeneration and, as a stabilizer, 5-1,000 ppm (weight) of an oil-soluble or oil-dispersible organic compound having a lipophilic hydrocarbyl chain having attached directly thereto at least two contiguous polar head functional groups, i.e., the functional groups are separated by no more than three carbon atoms. The diesel fuel composition is particularly suitable for use with diesel engines fitted with a particulate trap for emissions control.
Abstract:
The invention concerns a method for supplying iron, via the fuel, to the particulate trap of a diesel engine exhaust in a form suitable for promoting trap regeneration. The method involves the addition to the fuel of a defined colloid of iron oxide. Combustion of this colloid produces iron-containing compounds, especially iron oxides, which collect in association with carbonaceous particulate matter in the particulate trap, and function to promote the combustion of this matter.The colloid in particular shows a lower level of associated deposit formation on the fuel injectors than the iron additives of the prior art. The method is thus particularly suitable for modern engines showing increased susceptibility to fuel injector deposits. The colloid also shows a balance of properties providing excellent suitability for use as an additive in fuels, and especially in diesel engine on-board dosing devices.
Abstract:
An iron-containing polymer is provided for use as a fuel additive for promoting trap regeneration. The polymer shows a beneficial balance of physical properties, and is prepared from iron salts by a polymerisation process involving base addition, and subsequent coordination of branched-chain polycarboxylate ligands. The polymer can be stored in highly concentrate form, and shows particular suitability for on board dosing systems.
Abstract:
An iron-containing polymer is provided for use as a fuel additive for promoting trap regeneration. The polymer shows a beneficial balance of physical properties, and is prepared from iron salts by a polymerization process involving base addition, and subsequent co-ordination of branched-chain polycarboxylate ligands. The polymer can be stored in highly concentrate form, and shows particular suitability for on board dosing systems.
Abstract:
The invention concerns a method for supplying iron, via the fuel, to the particulate trap of a diesel engine exhaust in a form suitable for promoting trap regeneration. The method involves the addition to the fuel of a defined colloid of iron oxide. Combustion of this colloid produces iron-containing compounds, especially iron oxides, which collect in association with carbonaceous particulate matter in the particulate trap, and function to promote the combustion of this matter.The colloid in particular shows a lower level of associated deposit formation on the fuel injectors than the iron additives of the prior art. The method is thus particularly suitable for modern engines showing increased susceptibility to fuel injector deposits. The colloid also shows a balance of properties providing excellent suitability for use as an additive in fuels, and especially in diesel engine on-board dosing devices.
Abstract:
A synth .sup.99m Tc complex which contains the moiety Tc.dbd.NR, Tc--N.dbd.NY or Tc(--N.dbd.NY).sub.2 and an organic ligand which confers biological target-seeking properties on the technetium complex, where R is an aryl group, a substituted or unsubstituted alkyl group or the group --NR.sup.1 R.sup.2 ; Y is an aryl group or a substituted or unsubstituted alkyl group; and R.sup.1 and R.sup.2 are H, aryl groups or substituted or unsubstituted aliphatic or cyclic alkyl groups, and are the same or different provided that both are not hydrogen. Radiopharmaceuticals comprising this complex are also described, together with methods for the preparation of the complex.
Abstract:
Novel complexes of technetium (.sup.99 Tc or .sup.99m Tc) which contain the moiety Tc.dbd.NR, Tc--N.dbd.NY or Tc(--N.dbd.NY).sub.2, and a ligand which confers biological target-seeking properties on the complex, wherein R represents an aryl group, a substituted or unsubstituted alkyl group, or the grouping .dbd.NR.sup.1 R.sup.2 ; Y represents an aryl group or a substituted or unsubstituted alkyl group; and R.sup.1 and R.sup.2 are hydrogen, aryl groups or substituted or unsubstituted aliphatic or cyclic alkyl groups, and may be both the same or different, provided that both are not hydrogen. The complexes are suitable for use in radiopharmaceuticals for a variety of clinical applications. Methods for the preparation of these technetium complexes are also described.
Abstract translation:含有部分Tc = NR,Tc-N = NY或Tc(-N = NY)2的锝(99Tc或99mTc)的新型络合物和赋予复合物生物靶寻求性质的配体,其中R表示 芳基,取代或未取代的烷基,或基团= NR 1 R 2; Y表示芳基或取代或未取代的烷基; 并且R 1和R 2是氢,芳基或取代或未取代的脂族或环状烷基,并且可以相同或不同,条件是两者都不是氢。 该配合物适用于各种临床应用的放射性药物。 还描述了制备这些锝络合物的方法。
Abstract:
A 99mTc complex which contains the moiety Tc═NR, Tc—N═NY or Tc(—N═NY)2, and as a synthetic organic ligand which confers biological target-seeking properties on the technetium complex, where: R is an aryl group, a substituted or unsubstituted alkyl group or the group —NR1R2; Y is an aryl group or a substituted or unsubstituted alkyl group; R1 and R2 are H, aryl groups or substituted or unsubstituted aliphatic or cyclic alkyl groups, and are the same or different provided that both are not hydrogen; where at least one of the R or Y groups comprises an aryl group which chelates the 99mTc.
Abstract:
.sup.99m Tc complexes of formula L.sub.n Tc.dbd.NR, L.sub.n Tc--N.dbd.NY, or L.sub.n Tc--(N.dbd.NY).sub.2 wherein each L is independently a monodentate or multidentate ligand;Y is a substituted or unsubstituted aryl group or substituted or unsubstituted alkyl group;R is Y or the grouping --NR.sup.1 R.sup.2 ;n is 1-4;where at least one of R or Y is combined with one or more of the L groups; R.sup.1 and R.sup.2 are H, substituted or unsubstituted aryl groups or substituted or unsubstituted aliphatic or cyclic alkyl groups, and are the same or different, provided that both are not hydrogen.
Abstract:
A 99mTc complex which contains the moiety Tc═NR, Tc—N═NY or Tc(—N═NY)2, and as a synthetic organic ligand which confers biological target-seeking properties on the technetium complex, where: R is an aryl group, a substituted or unsubstituted alkyl group or the group —NR1R2; Y is an aryl group or a substituted or unsubstituted alkyl group; R1 and R2 are H, aryl groups or substituted or unsubstituted aliphatic or cyclic alkyl groups, and are the same or different provided that both are not hydrogen; where at least one of the R or Y groups comprises an aryl group which chelates the 99mTc.